LYTIR

Company · AEON

AEON Biopharma, Inc.

Nasdaq's symbol directory lists AEON on NYSE American as “AEON Biopharma, Inc. Class A Common Stock”.

In the 12 months to Nov 19, 2026: insiders bought on 1 occasion ($243K); 5 filings by holders of 5% or more; 4 company reports (Form 8-K, since May 26, 2026).

All insider filings at the SEC

Insider trades · SEC Form 4

Those inside the hall

Open-market purchases and sales only. Legs one person filed for one day are combined.

Who traded

  1. Timothy P. Lynch bought on 1 day latest Aug 19, 2026 bought $243K
Every trade (1)
  1. BUYTimothy P. Lynch bought Aug 19, 2026 1,150,000 shares filing $243K

Large holders · SEC Schedules 13D and 13G

Five percent and over

Anyone who comes to hold more than 5% of a company's voting shares must tell the SEC. A Schedule 13D is filed by a holder who may seek to influence the company; a 13G by one who states it is a passive investor. An amendment updates an earlier filing, and a stake reported as 0% means the holder says it has sold all, or nearly all, of its shares. Every recent 13D and 13G

  1. Ikarian Capital, LLC filed Nov 16, 2026 Schedule 13G passive filing 9.9%
  2. Nantahala Capital Management, LLC filed Nov 13, 2026 Schedule 13G passive filing 9.99%
  3. Daewoong Co., Ltd. filed Nov 10, 2026 Schedule 13D/A may seek influence 23,242,546 shares filing 30.6%
  4. LYNCH TIMOTHY P filed Aug 21, 2026 Schedule 13G passive 6,500,000 shares filing 13%
  5. Stonepine Capital Management, LLC filed Jul 21, 2026 Schedule 13G passive filing 9.9%

Company reports · SEC Form 8-K

In its own words

Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.

  1. Results of operations and financial condition filing Nov 16, 2026
  2. Entry into a material definitive agreement filing Nov 3, 2026
  3. Regulation FD disclosure filing Oct 23, 2026
  4. Regulation FD disclosure; Other events filing Sep 30, 2026

Sources: SEC EDGAR (Forms 4, 144 and 8-K) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.